The request for testing for the presence of COVID19 is escalating all over the world. Many concerns are expressed as to what tests should be performed, what is their accuracy, how long do the results take to reach the person being tested and the need for retesting. Diagnostic testing is the only way in which infection with COVID 19 can be confirmed. There are currently 3 reasons for testing as shown in the Table.
|Reason for testing|
|1||Diagnosis of disease caused by the virus||Presence of COVID19 virus confirmed in · a patient with symptoms suggestive of the infection. · follow up groups- patients who are CoVID confirmed (symptomatic or asymptomatic) undergo serial PCR testing to confirm viral clearance before discharge|
|2||As one strategy for reducing transmission||Presence of COVID 19 virus detected in an asymptomatic person who had contact with one or more people who COVID19 virus positive. These infected with COVID19 and could become ill and also could transmit the virus to others.|
|3||Surveillance||Determine who has been infected with the virus in a country or in a section of the country (eg: healthcare workers, armed forces, emergency workforce etc)|
Laboratory diagnosis of COVID19 virus infections
(with available tests at the time of writing)
This test detects the presence of the virus by identifying its genetic material. Diagnostic testing is carried out on 2 groups
- Patients – ie: those who have symptoms of the disease caused by the virus.
- Asymptomatic people – who are infected but don’t have any symptoms. This group of people may remain asymptomatic or become ill. They can be the sources for transmission (spread) of the virus.
Testing using this method is technically demanding and not all laboratories have the facilities and trained personnel to carry out testing.
In addition to confirming the diagnosis in patients who are ill, the test also provides valuable information for public health officials to isolate patients, both symptomatic and before symptoms start (also called pre-symptomatic) and trace contacts who are at risk of getting infected.
A limited number of laboratories in Sri Lanka are carrying out the test which is being expanded as more laboratories receive the required equipment and other materials needed for the test. The need for trained laboratory personnel remains a limitation to rapid expansion of testing capability. However, it must be emphasized that currently, this is the only test which demonstrates the presence of virus in patients as well as asymptomatic people.
Immunoglobulin M (IgM) and G (IgG) are proteins produced by our immune system when we encounter a virus, bacteria or any other foreign agent. IgM is produced first and then IgG. Both can be detected in the blood of an infected person and tests to detect these antibodies to COVID19 have been developed and are now available commercially. The advantages of these tests are that they are technically much less complex than the RT PCR and provide results in a much shorter time.
It is important to recognize that as these antibodies are produced only after the person is infected, they are not detected in the acute (early) part of the disease which is when we need to confirm the diagnosis. Detection of IgM is usually after the 7th day of illness. If these tests are used in the early stage of the illness, accurate diagnosis will not be possible and false negatives will be the norm. It is very important therefore that we do not replace RT PCR testing with IgM/G tests for diagnosis in symptomatic patients.
A second limitation of this group of tests is that they will be positive in anyone infected with COVID19 in the past. IgG remains positive for long periods of time and IgM for a variable period (usually a few weeks). If these tests are done on demand by persons unqualified to interpret them, many people would consider themselves infected and be worried that they will become ill and/or transmit the virus to others.
A third serious limitation is that there are different types of test kits to detect IgM/IgG. One group of tests are “rapid” tests that provide results within less than an hour. However, many such kits have low sensitivity and have been taken out of use the world over. Three CoViD -19 IgM/IgG Immunochromatographic test kits have been tested at MRI using whole blood of 16 CoViD-19 PCR positive patients with more than 10 to 19 days of symptoms. The sensitivity of these kits was very low, ranging from 6% to 31%, indicating their unsuitability for use. It is important to validate these kits before introducing for clinical use.
Other methods like ELISA generally have higher test performance indices.
- RT PCR to remain the test to identify the presence of the virus in COVID19 infection. It is therefore used to diagnose infection in patients with clinical symptoms who present early in their illness. Testing capability requires to be increased as is being done at the moment.
- IgM/IgG testing
- IgM testing is useful as a diagnostic test (preferably with RT PCR) in patients with clinical disease who present late in the disease.
- IgG and IgM are useful for sero-surveillance. They should be used in a planned study in specific populations to determine the spread of the virus (epidemiological study) the possible role of a protective immune response. All test kits used for this purpose should be validated before use, to ensure reliability of the results.
It is very important that serological tests (IgM/IgG detection) are not done ‘on demand’ as a diagnostic test as it will lead to many issues, which include
- If negative - a false sense of security that the person is not infected
- If positive - being falsely accused of being infected and infective and therefore a risk to others.